The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
The epidermal growth factor receptor variant III (EGFR v III): where wild things are altered
Open accessAbstract
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification. Tumors with EGFR gene amplification frequently contain EGFR gene rearrangements, with the most common extracellular domain mutation being EGFR v III. This mutation leads to a deletion of exons 2–7 of the EGFR gene and renders the mutant receptor incapable of binding any known ligand. Despite this, EGFR v III displays low‐level constitutive signaling that is augmented by reduced internalization and downregulation. Aberrant EGFR v III signaling has been shown to be important in driving tumor progression and often correlates with poor prognosis. It is clear that EGFR v III is expressed in a considerable proportion of patients with glioblastoma multiforme (GBM). The presence of EGFR v III in other tumor types, however, remains controversial. In this review, we critically analyze the evidence for the expression of EGFR v III in a range of tumor types and discuss recent findings pertinent to its function and biology in GBM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., & Rak, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1725 · Cited by 2,034
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Zhang, X., Gureasko, J., Shen, K., Cole, P. A., & Kuriyan, J. (2006) · Cell · doi:10.1016/j.cell.2006.05.013 · Cited by 1,650
Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., & Schlessinger, J. (1985) · Nature · doi:10.1038/313144a0 · Cited by 1,503
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442
The EGF receptor family as targets for cancer therapy
Mendelsohn, J., & Baselga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1204082 · Cited by 1,340
Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment
Giese, A., Bjerkvig, R., Berens, M. E., & Westphal, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.063 · Cited by 1,200
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., & Huang, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7727 · Cited by 936
Structural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Sampson, J. H., Heimberger, A. B., Archer, G. E., Aldape, K. D., Friedman, A. H., Friedman, H. S., Gilbert, M. R., Herndon, J. E., McLendon, R. E., Mitchell, D. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.6963 · Cited by 815
Autophosphorylation sites on the epidermal growth factor receptor
Downward, J., Parker, P., & Waterfield, M. D. (1984) · Nature · doi:10.1038/311483a0 · Cited by 704
Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
Shinojima, N., Tada, K., Shiraishi, S., Kamiryo, T., Kochi, M., Nakamura, H., Makino, K., Saya, H., Hirano, H., Kuratsu, J., et al. (2003) · PubMed · Cited by 663
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
Frederick, L. A., Wang, X. Y., Eley, G. D., & James, C. D. (2000) · PubMed · Cited by 661
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.
Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G. R., Zoltick, P. W., Biegel, J. A., Hayes, R. L., & Wong, A. J. (1995) · PubMed · Cited by 637
Ekstrand, A. J., James, C. D., Cavenee, W. K., Seliger, B., Pettersson, R. F., & Collins, V. P. (1991) · PubMed · Cited by 630
Smith, J. S., Tachibana, I., Passe, S. M., Huntley, B. K., Borell, T. J., Iturria, N., O'Fallon, J. R., Schaefer, P. L., Scheithauer, B. W., James, C. D., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.16.1246 · Cited by 630
Increased lipogenesis in cancer cells: new players, novel targets
Swinnen, J. V., Brusselmans, K., & Verhoeven, G. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232894.28674.30 · Cited by 610
Ekstrand, A. J., Sugawa, N., James, C. D., & Collins, V. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4309 · Cited by 602
Huang, H.-J. S., Nagane, M., Klingbeil, C. K., Lin, H., Nishikawa, R., Ji, X.-D., Huang, C.-M., Gill, G. N., Wiley, H. S., & Cavenee, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2927 · Cited by 595
Sugawa, N., Ekstrand, A. J., James, C. D., & Collins, V. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8602 · Cited by 594
Inda, M.-D.-M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D. W. Y., Vandenberg, S., Brennan, C., Johns, T. G., Bachoo, R., Hadwiger, P., et al. (2010) · Genes & Development · doi:10.1101/gad.1890510 · Cited by 543
Self-citationRude Voldborg, B., Damstrup, L., Spang-Thomsen, M., & Skovgaard Poulsen, H. (1997) · Annals of Oncology · doi:10.1023/a:1008209720526 · Cited by 528
Heimberger, A. B., Hlatky, R., Suki, D., Yang, D., Weinberg, J., Gilbert, M., Sawaya, R., & Aldape, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1737 · Cited by 516
(1997) · PubMed · Cited by 512
Sok, J. C., Coppelli, F. M., Thomas, S. M., Lango, M. N., Xi, S., Hunt, J. L., Freilino, M. L., Graner, M. W., Wikstrand, C. J., Bigner, D. D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0913 · Cited by 492
Li, D.-M., & Sun, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15406 · Cited by 489
Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, M. L., Humphrey, P. A., Kurpad, S. N., McLendon, R. E., Moscatello, D. K., Pegram, C. N., & Reist, C. J. (1995) · PubMed · Cited by 469
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib
Haas-Kogan, D. A., Prados, M. D., Tihan, T., Eberhard, D. A., Jelluma, N., Arvold, N. D., Baumber, R., Lamborn, K. R., Kapadia, A., Malec, M., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji161 · Cited by 465
Epidermal Growth Factor Receptor Dependence in Human Tumors: More Than Just Expression?
Arteaga, C. L. (2002) · The Oncologist · doi:10.1634/theoncologist.7-2004-31 · Cited by 455
Bianco, R., Shin, I., Ritter, C. A., Yakes, F. M., Basso, A., Rosen, N., Tsurutani, J., Dennis, P. A., Mills, G. B., & Arteaga, C. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206388 · Cited by 448
Nagane, M., Coufal, F. J., Lin, H., Bögler, O., Cavenee, W. K., & Huang, H.-J. S. (1996) · PubMed · Cited by 405
The EGFRvIII variant in glioblastoma multiforme
Gan, H. K., Kaye, A. H., & Luwor, R. B. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.12.005 · Cited by 396
Self-citationHuang, P. H., Mukasa, A., Bonavia, R., Flynn, R. A., Brewer, Z. E., Cavenee, W. K., Furnari, F. B., & White, F. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705158104 · Cited by 390
Humphrey, P. A., Wong, A. J., Vogelstein, B., Zalutsky, M. R., Fuller, G. N., Archer, G. E., Friedman, H. S., Kwatra, M. M., Bigner, S. H., & Bigner, D. D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4207 · Cited by 382
Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., & Park, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1093 · Cited by 382
Prados, M. D., Chang, S. M., Butowski, N., DeBoer, R., Parvataneni, R., Carliner, H., Kabuubi, P., Ayers-Ringler, J., Rabbitt, J., Page, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9639 · Cited by 378
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas
Chakravarti, A., Zhai, G., Suzuki, Y., Sarkesh, S., Black, P. M., Muzikansky, A., & Loeffler, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.193 · Cited by 377
Nagane, M., Levitzki, A., Gazit, A., Cavenee, W. K., & Huang, H.-J. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5724 · Cited by 363
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway
de la Iglesia, N., Konopka, G., Puram, S. V., Chan, J. A., Bachoo, R. M., You, M. J., Levy, D. E., DePinho, R. A., & Bonni, A. (2008) · Genes & Development · doi:10.1101/gad.1606508 · Cited by 336
Wikstrand, C. J., McLendon, R. E., Friedman, A. H., & Bigner, D. D. (1997) · PubMed · Cited by 332
Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.
Bigner, S. H., Humphrey, P. A., Wong, A. J., Vogelstein, B., Mark, J., Friedman, H. S., & Bigner, D. D. (1990) · PubMed · Cited by 331
Traxler, P., Allegrini, P. R., Brandt, R., Brueggen, J., Cozens, R., Fabbro, D., Grosios, K., Lane, H. A., McSheehy, P., Mestan, J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3681 · Cited by 320
Pelloski, C. E., Ballman, K. V., Furth, A. F., Zhang, L., Lin, E., Sulman, E. P., Bhat, K., McDonald, J. M., Yung, W. K. A., Colman, H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.0705 · Cited by 311
Moscatello, D. K., Holgado-Madruga, M., Emlet, D. R., Montgomery, R. B., & Wong, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.200 · Cited by 305
(2004) · The Women's Oncology Review · doi:10.3109/14733400410001727592 · Cited by 288
Batra, S. K., Castelino‐Prabhu, S., Wikstrand, C. J., Zhu, X., Humphrey, P. A., Friedman, H. S., & Bigner, D. D. (1995) · PubMed · Cited by 281
Activation of STAT proteins and growth control
Bromberg, J. F. (2001) · BioEssays · doi:10.1002/1521-1878(200102)23:2<161::aid-bies1023>3.0.co;2-0 · Cited by 279
Aldape, K. D., Ballman, K., Furth, A., Buckner, J. C., Giannini, C., Burger, P. C., Scheithauer, B. W., Jenkins, R. B., & James, C. D. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.700 · Cited by 278
Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.
Lal, A., Glazer, C. A., Martinson, H. M., Friedman, H. S., Archer, G. E., Sampson, J. H., & Riggins, G. J. (2002) · PubMed · Cited by 278
Brown, P. D., Krishnan, S., Sarkaria, J. N., Wu, W., Jaeckle, K. A., Uhm, J. H., Geoffroy, F. J., Arusell, R., Kitange, G., Jenkins, R. B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0612 · Cited by 277
Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance
Tanaka, K., Babic, I., Nathanson, D., Akhavan, D., Guo, D., Gini, B., Dang, J., Zhu, S., Yang, H., De Jesus, J., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0124 · Cited by 275
Mukherjee, B., McEllin, B., Camacho, C. V., Tomimatsu, N., Sirasanagandala, S., Nannepaga, S., Hatanpaa, K. J., Mickey, B., Madden, C., Maher, E., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4853 · Cited by 270
(2003) · PubMed · Cited by 269
Humphrey, P. A., Wong, A. J., Vogelstein, B., et al. (1988) · PubMed · Cited by 265
Ji, H., Zhao, X., Yuza, Y., Shimamura, T., Li, D., Protopopov, A., Jung, B. L., McNamara, K., Xia, H., Glatt, K. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510284103 · Cited by 257
Lo, H.-W., Cao, X., Zhu, H., & Ali-Osman, F. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4923 · Cited by 253
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.
de Palazzo, I. G., Adams, G. P., Sundareshan, P., Wong, A. J., Testa, J. R., Bigner, D. D., & Weiner, L. M. (1993) · PubMed · Cited by 243
Malignant glioma biology: Role for TGF-? in growth, motility, angiogenesis, and immune escape
Platten, M., Wick, W., & Weller, M. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4<401::aid-jemt1025>3.0.co;2-c · Cited by 242
Guo, D., Hildebrandt, I. J., Prins, R. M., Soto, H., Mazzotta, M. M., Dang, J., Czernin, J., Shyy, J. Y.-J., Watson, A. D., Phelps, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906606106 · Cited by 232
Reardon, D. A., & Wen, P. Y. (2006) · The Oncologist · doi:10.1634/theoncologist.11-2-152 · Cited by 231
Feldkamp, M. M., Feldkamp, M. M., Lala, P., Lau, N., Roncari, L., Guha, A., Guha, A., & Guha, A. (1999) · Neurosurgery · doi:10.1097/00006123-199912000-00034 · Cited by 227
Scott, A. M., Lee, F.-T., Tebbutt, N., Herbertson, R., Gill, S. S., Liu, Z., Skrinos, E., Murone, C., Saunder, T. H., Chappell, B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611693104 · Cited by 222
Self-citationYamazaki, H., Fukui, Y., Ueyama, Y., Tamaoki, N., Kawamoto, T., Taniguchi, S., & Shibuya, M. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.4.1816 · Cited by 212
Chakravarti, A., Chakladar, A., Delaney, M. A., Latham, D. E., & Loeffler, J. S. (2002) · PubMed · Cited by 212
Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR
Pandita, A., Aldape, K. D., Zadeh, G., Guha, A., & James, C. D. (2004) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10300 · Cited by 211
Transformational and altered signal transduction by a naturally occurring mutant EGF receptor.
Moscatello, D. K., Montgomery, B., Sundareshan, P., McDanel, H. J., Wong, M. Y., & Wong, A. J. (1996) · PubMed · Cited by 207
Mishima, K., Johns, T. G., Luwor, R. B., Scott, A. M., Stockert, E., Jungbluth, A. A., Ji, X.-D., Suvarna, P., Voland, J. R., Old, L. J., et al. (2001) · PubMed · Cited by 204
Self-citationGolding, S. E., Morgan, R. N., Adams, B. R., Hawkins, A. J., Povirk, L. F., & Valerie, K. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.8.7927 · Cited by 202
Wu, G., Barth, R. F., Yang, W., Chatterjee, M., Tjarks, W., Ciesielski, M. J., & Fenstermaker, R. A. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0341674 · Cited by 193
Narita, Y., Nagane, M., Mishima, K., Huang, H.-J. S., Furnari, F. B., & Cavenee, W. K. (2002) · PubMed · Cited by 189
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors
Sampson, J. H., Crotty, L. E., Lee, S., Archer, G. E., Ashley, D. M., Wikstrand, C. J., Hale, L. P., Small, C., Dranoff, G., Friedman, A. H., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130166597 · Cited by 188
CHU, C. T., EVERISS, K. D., WIKSTRAND, C. J., BATRA, S. K., KUNG, H.-J., & BIGNER, D. D. (1997) · Biochemical Journal · doi:10.1042/bj3240855 · Cited by 184
The Role of AMPK and mTOR in Nutrient Sensing in Pancreatic β-Cells
Gleason, C. E., Lu, D., Witters, L. A., Newgard, C. B., & Birnbaum, M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610631200 · Cited by 179
Prigent, S. A., Nagane, M., Lin, H., Huvar, I., Boss, G. R., Feramisco, J. R., Cavenee, W. K., & Huang, H.-J. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25639 · Cited by 175
Jungbluth, A. A., Stockert, E., Huang, H. J. S., Collins, V. P., Coplan, K., Iversen, K., Kolb, D., Johns, T. J., Scott, A. M., Gullick, W. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232686499 · Cited by 174
Self-citationMizoguchi, M., Betensky, R. A., Batchelor, T. T., Bernay, D. C., Louis, D. N., & Nutt, C. L. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000248549.14962.b2 · Cited by 171
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
Bonavia, R., Inda, M. M., Vandenberg, S., Cheng, S.-Y., Nagane, M., Hadwiger, P., Tan, P., Sah, D. W. Y., Cavenee, W. K., & Furnari, F. B. (2012) · Oncogene · doi:10.1038/onc.2011.563 · Cited by 170
Heimberger, A. B., Learn, C. A., Archer, G. E., McLendon, R. E., Chewning, T. A., Tuck, F. L., Pracyk, J. B., Friedman, A. H., Friedman, H. S., Bigner, D. D., et al. (2002) · PubMed · Cited by 169
Li, B., Yuan, M., Kim, I.-A., Chang, C.-M., Bernhard, E. J., & Shu, H.-K. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207602 · Cited by 168
Schmidt, M. H. H., Furnari, F. B., Cavenee, W. K., & Bögler, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031790100 · Cited by 164
Learn, C. A., Hartzell, T. L., Wikstrand, C. J., Archer, G. E., Rich, J. N., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Sampson, J. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0521 · Cited by 160
Constitutive Activation of c-Jun N-terminal Kinase by a Mutant Epidermal Growth Factor Receptor
Antonyak, M. A., Moscatello, D. K., & Wong, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2817 · Cited by 159
Yamazaki, H., Ohba, Y., Tamaoki, N., & Shibuya, M. (1990) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1990.tb02644.x · Cited by 158
Lu, K. V., Zhu, S., Cvrljevic, A., Huang, T. T., Sarkaria, S., Ahkavan, D., Dang, J., Dinca, E. B., Plaisier, S. B., Oderberg, I., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0347 · Cited by 158
Self-citationMalden, L. T., Novak, U., Kaye, A. H., & Burgess, A. W. (1988) · PubMed · Cited by 156
Abulrob, A., Giuseppin, S., Andrade, M. F., McDermid, A., Moreno, M., & Stanimirovic, D. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207911 · Cited by 147
Gan, H. K., Burgess, A. W., Clayton, A. H. A., & Scott, A. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3898 · Cited by 147
Self-citationLassus, H. J., Sihto, H. J., Leminen, A., Joensuu, H., Isola, J. J., Nupponen, N. N., & Bützow, R. C. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0054-4 · Cited by 146
Glycosylation-induced Conformational Modification Positively Regulates Receptor-Receptor Association
Fernandes, H., Cohen, S., & Bishayee, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005599200 · Cited by 144
Ramnarain, D. B., Park, S., Lee, D. Y., Hatanpaa, K. J., Scoggin, S. O., Otu, H., Libermann, T. A., Raisanen, J. M., Ashfaq, R., Wong, E. T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2753 · Cited by 140
Choi, B. D., Kuan, C., Cai, M., Archer, G. E., Mitchell, D. A., Gedeon, P. C., Sanchez-Perez, L. A., Pastan, I. H., Bigner, D. D., & Sampson, J. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219817110 · Cited by 138
Larsen, A. B., Pedersen, M. W., Stockhausen, M., Grandal, M. V., van Deurs, B., & Poulsen, H. S. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0321 · Cited by 137
Rong, Y., Belozerov, V. E., Tucker‐Burden, C., Chen, G., Durden, D. L., Olson, J. J., Meir, E. G. V., Mackman, N., & Brat, D. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1547 · Cited by 134
Johns, T. G., Stockert, E., Ritter, G., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10189 · Cited by 131
Self-citationPredominant Expression of Mutant EGFR (EGFRvIII) is Rare in Primary Glioblastomas
Biernat, W., Huang, H., Yokoo, H., Kleihues, P., & Ohgaki, H. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00045.x · Cited by 129
Kaur, B., Cork, S. M., Sandberg, E. M., Devi, N. S., Zhang, Z., Klenotic, P. A., Febbraio, M., Shim, H., Mao, H. Z., Tucker‐Burden, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1166 · Cited by 126
Ge, H., Gong, X., & Tang, C. K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10224 · Cited by 124
Feldkamp, M. M., Lau, N. C., Rak, J. W., Kerbel, R. S., & Guha, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990331)81:1<118::aid-ijc20>3.0.co;2-5 · Cited by 124
Kong, L.-Y., Abou-Ghazal, M. K., Wei, J., Chakraborty, A., Sun, W., Qiao, W., Fuller, G. N., Fokt, I., Grimm, E. A., Schmittling, R. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0377 · Cited by 124
(2004) · The Women s Oncology Review · doi:10.1080/14733400410001727592 · Cited by 120
Pillay, V., Allaf, L., Wilding, A. L., Donoghue, J. F., Court, N. W., Greenall, S. A., Scott, A. M., & Johns, T. G. (2009) · Neoplasia · doi:10.1593/neo.09230 · Cited by 119
Self-citationMontgomery, B., Guzman, J., O’Rourke, D. M., & Stahl, W. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000966200 · Cited by 115
Feldkamp, M. M., Lau, N. C., & Guha, A. (1999) · Oncogene · doi:10.1038/sj.onc.1203105 · Cited by 113
Yang, W., Wu, G. J., Barth, R. F., Swindall, M., Bandyopadhyaya, A. K., Tjarks, W., Tordoff, K. P., Moeschberger, M. L., Sferra, T. J., Binns, P. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1968 · Cited by 108
Allen, C., Vongpunsawad, S., Nakamura, T., James, C. D., Schroeder, M. A., Cattaneo, R., Giannini, C., Krempski, J. W., Peng, K.-W., Goble, J. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1200 · Cited by 107
Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples
Yoshimoto, K., Dang, J. H. T., Zhu, S., Nathanson, D. A., Huang, T., Dumont, R. A., Seligson, D. B., Yong, W. H., Xiong, Z., Rao, N. P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1966 · Cited by 107
Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors
Freeman, S. S., Allen, S. W., Ganti, R., Wu, J., Ma, J., Su, X., Neale, G. A. M., Dome, J. S., Daw, N. C., & Khoury, J. D. (2008) · Cancer · doi:10.1002/cncr.23782 · Cited by 105
The Role of HER1-HER4 and EGFRvIII in Hormone-Refractory Prostate Cancer
Edwards, J., Traynor, P., Munro, A. F., Pirret, C. F., Dunne, B., & Bartlett, J. M. S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1445 · Cited by 104
Heimberger, A. B., Archer, G. E., Alexander, L. E. C., McLendon, R. E., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Sampson, J. H. (2002) · Neurosurgery · doi:10.1097/00006123-200201000-00024 · Cited by 104
Patel, T. B. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.4 · Cited by 104
p27Kip1 is required for PTEN-induced G1 growth arrest.
GOTTSCHALK, A. R., Basila, D., Wong, M., Dean, N. M., Brandts, C., Stokoe, D., & Haas-Kogan, D. A. (2001) · PubMed · Cited by 103
Perera, R. M., Narita, Y., Furnari, F. B., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2653 · Cited by 103
Yang, W., Barth, R. F., Wu, G. J., Kawabata, S., Sferra, T. J., Bandyopadhyaya, A. K., Tjarks, W., Ferketich, A. K., Moeschberger, M. L., Binns, P. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0141 · Cited by 103
Liu, L., Bäcklund, L. M., Nilsson, B. R., et al. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0700-2 · Cited by 103
EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors
Li, L., Dutra, A., Pak, E. D., Labrie, J. E., Gerstein, R. M., Pandolfi, P. P., Recht, L. D., & Ross, A. H. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-081 · Cited by 100
Pal, A., Glekas, A., Doubrovin, M., Balatoni, J., Beresten, T., Maxwell, D. S., Soghomonyan, S., Shavrin, A., Ageyeva, L., Finn, R., et al. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0049-0 · Cited by 99
Johns, T. G., Luwor, R. B., Murone, C., Walker, F., Weinstock, J., Vitali, A. A., Perera, R. M., Jungbluth, A. A., Stockert, E., Old, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036503100 · Cited by 99
Self-citationNieto, Y. L., Nawaz, F., Jones, R. B., Shpall, E. J., & Nawaz, S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.8822 · Cited by 96
19F- and Fluorescently Labeled Micelles as Nanoscopic Assemblies for Chemotherapeutic Delivery
Du, W., Xu, Z., Nyström, A. M., Zhang, K., Leonard, J. R., & Wooley, K. L. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800396h · Cited by 93
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
de Graeff, P., Crijns, A. P. G., ten Hoor, K. A., Klip, H. G., Hollema, H., Oien, K. A., Bartlett, J. M. S., Wisman, G. B. A., de Bock, G. H., de Vries, E. G. E., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604471 · Cited by 93
Montgomery, B., Moscatello, D. K., Wong, A. J., Cooper, J. A., & Stahl, W. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30562 · Cited by 87
Martens, T., Laabs, Y., Günther, H. S., Kemming, D., Zhu, Z., Witte, L., Hagel, C., Westphal, M., & Lamszus, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0147 · Cited by 87
Kelly, T., Kechelava, S., Rozypal, T. L., et al. (1998) · PubMed · Cited by 83
Nagane, M., Narita, Y., Mishima, K., Levitzki, A., Burgess, A. W., Cavenee, W. K., & Huang, H. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.95.3.0472 · Cited by 83
EGFRvIII-mediated radioresistance through a strong cytoprotective response
Lammering, G., Hewit, T. H., Valerie, K. C., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206788 · Cited by 82
Proteins and Protein Pattern Differences between Glioma Cell Lines and Glioblastoma Multiforme
Vogel, T. W. A., Zhuang, Z., Li, J., Okamoto, H., Furuta, M., Lee, Y., Zeng, W., Oldfield, E. H., Vortmeyer, A. O., & Weil, R. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2115 · Cited by 81
Johns, T., Perera, R., Vernes, S., Vitali, A., Cao, D., Cavenee, W., Scott, A., & Furnari, F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1453 · Cited by 80
Self-citationSchulte, A., Günther, H. S., Martens, T., Zapf, S., Riethdorf, S., Wülfing, C., Stoupiec, M., Westphal, M., & Lamszus, K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3084 · Cited by 78
Johns, T. G., Mellman, I., Cartwright, G. A., Ritter, G., Old, L. J., Burgess, A. W., & Scott, A. M. (2005) · The FASEB Journal · doi:10.1096/fj.04-1766fje · Cited by 78
Self-citationHypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII
Han, W., Zhang, T., Yu, H. W., Foulke, J. G., & Tang, C. K. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3226 · Cited by 77
LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII
Stutz, M. A., Shattuck, D. L., Laederich, M. B., Carraway, K. L., & Sweeney, C. A. (2008) · Oncogene · doi:10.1038/onc.2008.185 · Cited by 77
Feng, H., Hu, B., Jarzynka, M. J., Li, Y., Keezer, S. M., Johns, T. G., Tang, C. K., Hamilton, R. L., Vuori, K., Nishikawa, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121457109 · Cited by 72
Self-citationOhtsuka, K., Ohnishi, H., Fujiwara, M., Kishino, T., Matsushima, S., Furuyashiki, G., Takei, H., Koshiishi, Y., Goya, T., & Watanabe, T. (2007) · Cancer · doi:10.1002/cncr.22476 · Cited by 72
Lorimer, I. A. J., Wikstrand, C. J., Batra, S. K., Bigner, D. D., & Pastan, I. (1995) · PubMed · Cited by 69
Genetically engineered T cells to target EGFRvIII expressing glioblastoma
Bullain, S., Sahin, A., Szentirmai, O., Sanchez, C., Lin, N., Baratta, E., Waterman, P. R., Weissleder, R., Mulligan, R. C., & Carter, B. S. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9889-1 · Cited by 67
Viana‐Pereira, M., Lopes, J. M., Little, S., Milanezi, F., Basto, D., Pardal, F., Jones, C., & Reis, R. M. (2008) · PubMed · Cited by 67
Hills, D., Rowlinson‐Busza, G., & Gullick, W. J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630414 · Cited by 64
Cemeus, C., Zhao, T., Barrett, G. M., Lorimer, I. A. J., & Dimitroulakos, J. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9627-0 · Cited by 63
Blehm, K., Spiess, P. E., Bondaruk, J. E., Dujka, M. E., Villares, G. J., Zhao, Y.-J., Bögler, O., Aldape, K., Grossman, H. B., Adam, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0407 · Cited by 63
Yang, W., Barth, R. F., Wu, G. J., Ciesielski, M. J., Fenstermaker, R. A., Moffat, B. A., Ross, B. D., & Wikstrand, C. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.341.11.1 · Cited by 61
Wang, S., Guo, P., Wang, X., Zhou, Q. S., & Gallo, J. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2070 · Cited by 59
Fukai, J., Nishio, K., Itakura, T., & Koizumi, F. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00945.x · Cited by 57
Expression of collagenase‐3 (MMP‐13) enhances invasion of human fibrosarcoma HT‐1080 cells
Ala‐aho, R., Johansson, N., Baker, A. H., & Kähäri, V. (2001) · International Journal of Cancer · doi:10.1002/ijc.1619 · Cited by 54
Expression of EGFR variant vIII promotes both radiation resistance and hypoxia tolerance
Weppler, S. A., Li, Y., Dubois, L. J., Lieuwes, N. G., Jutten, B., Lambin, P., Wouters, B. G., & Lammering, G. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.025 · Cited by 53
Li, D., Ji, H., Zaghlul, S., McNamara, K. L., Liang, M., Shimamura, T., Kubo, S., Takahashi, M., Chirieac, L. R., Padera, R. F., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30446 · Cited by 53
Pedersen, M. W., Pedersen, N. M., Damstrup, L., Villingshøj, M., Sønder, S. U., Rieneck, K., Bovin, L. F., Spang‐Thomsen, M., & Poulsen, H. S. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20554 · Cited by 53
Ning, Y., Zeineldin, R., Liu, Y., Rosenberg, M. J., Stack, M. S., & Hudson, L. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0407 · Cited by 49
Zhan, Y., Counelis, G. J., & O’Rourke, D. M. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.05.001 · Cited by 48
Panousis, C., Rayzman, V., Johns, T. G., Renner, C., Liu, Z., Cartwright, G. A., Lee, F.-T., Wang, D., Gan, H. K., Cao, D., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602470 · Cited by 48
Self-citationCvrljevic, A. N., Akhavan, D., Wu, M., Martinello, P., Furnari, F. B., Johnston, A. J., Guo, D., Pike, L. S., Cavenee, W. K., Scott, A. M., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.083295 · Cited by 47
Self-citationJutten, B., Dubois, L. J., Li, Y., Aerts, H. J. W. L., Wouters, B. G., Lambin, P., Theys, J., & Lammering, G. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.021 · Cited by 47
Ymer, S. I., Greenall, S. A., Cvrljevic, A. N., Cao, D. X., Donoghue, J. F., Epa, V. C., Scott, A. M., Adams, T. E., & Johns, T. G. (2011) · Cancers · doi:10.3390/cancers3022032 · Cited by 46
Self-citationArjona, D., Bello, M. J., Alonso, M. E., et al. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00653.x · Cited by 45
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity
Piao, Y., Jiang, H., Alemany, R., Krasnykh, V. N., Marini, F. C., Xu, J., Alonso, M. M., Conrad, C. A., Aldape, K., Gomez‐Manzano, C., et al. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.75 · Cited by 44
Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies
Witusik‐Perkowska, M., Rieske, P., Hułas-Bigoszewska, K., Zakrzewska, M., Stawski, R. S., Kulczycka-Wojdala, D., Bieńkowski, M., Stoczyńska-Fidelus, E., Grešner, S. M., Piaskowski, S., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0352-0 · Cited by 44
Ohtsuka, K., Ohnishi, H., Furuyashiki, G., Nogami, H., Koshiishi, Y., Ooide, A., Matsushima, S., Watanabe, T., & Goya, T. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)30407-x · Cited by 43
Ntayi, C., Lorimier, S., Berthier‐Vergnes, O., Hornebeck, W., & Bernard, P. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5306 · Cited by 42
Wang, H., Jiang, H., Zhou, M., Xu, Z., Liu, S., Shi, B., Xiao, Y., Yao, M., Gu, J., & Li, Z. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.019 · Cited by 42
Klingler‐Hoffmann, M., Bukczynska, P. E., & Tiganis, T. (2003) · International Journal of Cancer · doi:10.1002/ijc.11085 · Cited by 41
Sonnweber, B., Dlaska, M., Skvortsov, S., Dirnhofer, S., Schmid, T. A., & Hilbe, W. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.027615 · Cited by 40
Regulation of HGF Expression by ΔEGFR-Mediated c-Met Activation in Glioblastoma Cells
Garnett, J., Chumbalkar, V. C., Vaillant, B. D., Gururaj, A. E., Hill, K. S., Latha, K., Yao, J., Priebe, W., Colman, H., Elferink, L. A., et al. (2013) · Neoplasia · doi:10.1593/neo.121536 · Cited by 40
Function of aberrant EGFR in malignant gliomas
Sugawa, N., Yamamoto, K., Ueda, S., et al. (1998) · Brain Tumor Pathology · doi:10.1007/bf02482101 · Cited by 38
Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII
Aerts, H. J. W. L., Dubois, L. J., Hackeng, T. M., et al. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.030 · Cited by 36
EGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins
Davies, G., Ryan, P. E., Rahman, L., Zajac‐Kaye, M., & Lipkowitz, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209662 · Cited by 34
Tawbi, H. A.-H., Thomas, D. G., Lucas, D. R., Biermann, J. S., Schuetze, S. M., Hart, A. L., Chugh, R. K., & Baker, L. H. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0166 · Cited by 34
Wang, S., Zhou, Q. S., & Gallo, J. M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0089 · Cited by 32
Joughin, B. A., Naegle, K. M., Huang, P. H., Yaffe, M. B., Lauffenburger, D. A., & White, F. M. (2008) · Molecular BioSystems · doi:10.1039/b815075c · Cited by 31
Kim, K., Brush, J. M., Watson, P. A., Cacalano, N. A., Iwamoto, K. S., & McBride, W. H. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0313 · Cited by 30
Mutant Epidermal Growth Factor Receptor in Benign, Borderline, and Malignant Ovarian Tumors
Steffensen, K. D., Waldstrøm, M., Olsen, D. A., Corydon, T. J., Lorentzen, K. A., Knudsen, H. J., Jeppesen, U., Brandslund, I., & Jakobsen, A. K. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4171 · Cited by 29
Longo, J. F., Johnson, S. A. S., & Johnson, D. L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00288-08 · Cited by 26
Suppression of EGFRvIII‐mediated proliferation and tumorigenesis of breast cancer cells by ribozyme
Luo, X., Gong, X., & Tang, C. K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11007 · Cited by 25
Gan, H. K., Lappas, M., Cao, D. X., Cvrljevdic, A., Scott, A. M., & Johns, T. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00783.x · Cited by 24
Self-citationJohns, T. G., McKay, M. J., Cvrljevic, A. N., Gan, H. K., Taylor, C., Xu, H., Smyth, F. E., & Scott, A. M. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.03.027 · Cited by 20
Self-citationShankar, S., Vaidyanathan, G., Kuan, C., et al. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.08.004 · Cited by 18
Lack of the type III epidermal growth factor receptor mutation in colorectal cancer.
Spindler, K. G., Olsen, D. A., Nielsen, J. N., Brandslund, I., Poulsen, H. S., Villingshøj, M., & Jakobsen, A. K. M. (2006) · PubMed · Cited by 17
Montgomery, B. (2002) · International Journal of Cancer · doi:10.1002/ijc.10560 · Cited by 16
Improved Response by Co-targeting EGFR/EGFRvIII and Src Family Kinases in Human Cancer Cells
Andersen, P., Villingshøj, M., Poulsen, H. S., & Stockhausen, M. (2009) · Cancer Investigation · doi:10.1080/07357900802570759 · Cited by 14
Epidermal Growth Factor Receptor Stimulation of Diacylglycerol Kinase
Montgomery, B., Moscatello, D. K., Wong, A. J., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6237 · Cited by 9
Cited by
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Becker, A., Thakur, B. K., Weiss, J. M., Kim, H. S., Peinado, H., & Lyden, D. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.009 · Cited by 2,003
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Wee, P., & Wang, Z. (2017) · Cancers · doi:10.3390/cancers9050052 · Cited by 2,027
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336
Exploring the next generation of antibody–drug conjugates
Tsuchikama, K., Anami, Y., Ha, S. Y. Y., & Yamazaki, C. M. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00850-2 · Cited by 659
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Sturm, D., Bender, S., Jones, D. T. W., Lichter, P., Grill, J., Becher, O., Hawkins, C., Majewski, J., Jones, C., Costello, J. F., et al. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3655 · Cited by 555
Metadata
- Authors
- Gan, H. K., Cvrljevic, A. N., & Johns, T. G.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2013-07-08
- Volume
- 280
- Issue
- 21
- Pages
- 5350-5370
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2092692114
- Cited by
- 370
- References
- 181
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.